TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A study published in Nature Communications links elevated Miro1 in skeletal muscle with impaired insulin response in type 2 diabetes. Removing the protein restored insulin response in preclinical models, while participants with obesity and type 2 diabetes who exercised had lower muscle Miro1 levels and improved insulin sensitivity. The findings do not establish a Miro1-based treatment for people.
A study published October 19 in Nature Communications links elevated levels of the mitochondrial protein Miro1 in skeletal muscle with insulin resistance in people with type 2 diabetes. Researchers reported that removing Miro1 restored muscle response to insulin in preclinical models, while participants with obesity and type 2 diabetes who took part in an exercise trial had lower muscle Miro1 levels and improved insulin sensitivity.
The team examined Miro1 in cells, preclinical models and people with type 2 diabetes. Miro1, or Mitochondrial Rho GTPase 1, is located on the outer membrane of mitochondria, structures within cells that produce energy. The study reports that Miro1 accumulation impaired muscle response to insulin, and that removing the protein restored that response in the models used.
The human findings came from a randomized controlled trial involving people with obesity and type 2 diabetes. Researchers compared aerobic exercise with standard medical care. The exercise group showed reductions in muscle Miro1, along with improvements in insulin sensitivity and the muscles’ ability to produce energy, according to the report. The supplied material does not give participant numbers or the size of these changes.
The research was led by John P. Kirwan, who conducted the work at Pennington Biomedical Research Center and has since joined the University of Oklahoma’s Harold Hamm Diabetes Center. Elizabeth Heintz was the first author, and Christopher Axelrod was co-corresponding author. The paper is titled “Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes,” and carries DOI 10.1038/s41467-026-77278-6.
Miro1 Could Clarify Muscle Insulin Resistance
Insulin resistance in skeletal muscle is a feature of type 2 diabetes: muscle cells respond less effectively to insulin, which helps regulate blood glucose. The study offers evidence that Miro1 may be involved in that impaired response, connecting a mitochondrial protein with muscle function and insulin sensitivity.
The results also provide a possible molecular link to exercise. In the trial described by the researchers, exercise was associated with lower Miro1 levels as well as improvements in insulin sensitivity and energy production in muscle. That finding adds a potential biological explanation for the observed exercise effects; it does not show that Miro1 alone accounts for them.
Kirwan said the findings identify a potential therapeutic target and could inform future treatments that complement exercise. That is a research possibility, not an available treatment: the study does not establish that deliberately targeting Miro1 is safe or effective in patients.
high-protein meal replacement shakes for diabetes
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Muscle Cells to Human Exercise
The research used a sequence of approaches to examine whether Miro1’s relationship to insulin resistance extended beyond laboratory observations. The team studied the protein in cells and preclinical models, then considered its levels in people with type 2 diabetes. This allowed the researchers to compare mechanistic findings with human observations, though the different parts of the work answer different questions.
In particular, removing Miro1 and restoring insulin response in preclinical models supports a causal role within those models. The exercise trial, by contrast, showed that exercise and lower Miro1 levels occurred together in participants. The supplied report does not establish that the Miro1 reduction itself caused the improvements in insulin sensitivity. Kirwan’s program is continuing at the Harold Hamm Diabetes Center, where the stated aim is to connect laboratory studies with research in people.
““Miro1 accumulation impairs the muscle’s response to insulin, that removing it causally restores that response in our models, and that exercise reverses its buildup in people.””
— John P. Kirwan, senior author
caffeinated protein drinks for energy
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Treatment Potential Still Unproven
The findings do not show that a medicine targeting Miro1 can treat or prevent type 2 diabetes. The report says more research is needed to determine whether targeting the protein could lead to new treatments. It also does not provide details such as the number of trial participants, the magnitude or duration of the reported changes, or whether benefits persisted after the exercise intervention.
It remains unclear how Miro1 relates to other processes that affect insulin resistance, and whether reducing the protein would produce meaningful benefits beyond those observed in this study. The exercise results are evidence of an association in the trial, while the reported restoration after Miro1 removal was in preclinical models; those findings should not be treated as interchangeable proof in patients.
protein bars for blood sugar control
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Further Studies Must Test Miro1
Researchers will need to test whether Miro1 can be safely and effectively targeted and whether changes in the protein lead to lasting improvements in insulin sensitivity in people. The study’s publication provides a basis for that work, but the source material does not name a scheduled follow-up trial or a date for further results.
Kirwan is expected to continue translational research at the Harold Hamm Diabetes Center, connecting laboratory investigations with studies in people. For now, the reported findings add a candidate mechanism and potential target for research; they do not change the established need for patients to make treatment decisions with qualified health professionals.
exercise equipment for insulin sensitivity
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is Miro1?
Miro1, short for Mitochondrial Rho GTPase 1, is a protein found on the outer membrane of mitochondria, which produce energy inside cells.
What did the study find about Miro1 and type 2 diabetes?
The researchers linked elevated skeletal-muscle Miro1 with impaired insulin response. Removing the protein restored the response in preclinical models; the study does not establish that removal would do so in people.
Did exercise affect Miro1 levels?
In the reported randomized trial involving people with obesity and type 2 diabetes, the exercise group had lower muscle Miro1 levels and improved insulin sensitivity and muscle energy production. The source does not provide the size or duration of those changes.
Is there a Miro1 treatment available?
No Miro1-targeting treatment is established by this research. The authors say further research is needed to determine whether targeting the protein could produce a treatment.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
